FYCvsIBRN
FIRST TRUST SMALL CAP GROWTH ALPHADEX FUND against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| FYC | IBRN | |
|---|---|---|
| Expense ratio | — | 0.47% |
| Assets | $319M | $7864.21T |
| Net flow, 1 month | — | +$2M |
| Net flow, 1 year | — | +$2M |
| Return, YTD | +25.8% | +24.7% |
| Return, 1 year | +41.3% | +57.5% |
| Avg daily volume | 91K | 3K |
| Holdings | 265 | 54 |
| Listed | Feb 28, 2024 | Aug 23, 2022 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS